Neuraegis Inc.

Irvine, CA

UEI
Z9HYPA6YLBJ3
CAGE
7PKW7
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
5001 Alcorn Ln #253, Irvine, CA 92603, USA
Website
neuraegis.com
Founded
2016
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Testing the effects of a selective calpain-2 inhibitor on spontaneous recurrent seizures in mouse models of epilepsy R41NS130825 National Institute of Neurological Disorders and Stroke (NIH) $1,195,865

Quick answers

Is Neuraegis Inc. registered in SAM.gov?

Yes. Neuraegis Inc.'s SAM.gov registration is active through December 16, 2026.

What is Neuraegis Inc.'s most recent federal award?

Neuraegis Inc.'s most recent federal grant award is Testing the effects of a selective calpain-2 inhibitor on spontaneous recurrent seizures in mouse models of epilepsy (R41NS130825), from National Institute of Neurological Disorders and Stroke (NIH), on September 1, 2023.

On GovTribe

See Neuraegis Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login